Edwards Lifesciences's revenue per share for the
three
months ended in Dec. 2023 was $2.53.
Edwards Lifesciences's revenue per share for the trailing twelve months (TTM) ended in Dec. 2023 was $9.85.
Good Sign:
Edwards Lifesciences Corp has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue Per Share Growth Rate of Edwards Lifesciences was 14.30% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 12.40% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 10.60% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 12.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Edwards Lifesciences's Revenue per Share or its related term are showing as below:
EW'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -9.7 Med: 11.7 Max: 15.5
Current: 12.4
During the past 13 years, Edwards Lifesciences's highest 3-Year average Revenue Per Share Growth Rate was 15.50% per year. The lowest was -9.70% per year. And the median was 11.70% per year.
EW's 3-Year Revenue Growth Rate is ranked better than 62.31% of 743
companies
in the Medical Devices & Instruments industry
Industry Median: 7.5
vs EW: 12.40
Edwards Lifesciences Revenue per Share Historical Data
The historical data trend for Edwards Lifesciences's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Edwards Lifesciences's Revenue per Share
For the Medical Devices subindustry, Edwards Lifesciences's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Edwards Lifesciences's PS Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's PS Ratio distribution charts can be found below:
* The bar in red indicates where Edwards Lifesciences's PS Ratio falls into.
Edwards Lifesciences Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Edwards Lifesciences's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.85
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Edwards Lifesciences (NYSE:EW) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Edwards Lifesciences Revenue per Share Related Terms
Thank you for viewing the detailed overview of Edwards Lifesciences's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Edwards Lifesciences (Edwards Lifesciences) Business Description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EW has been successfully added to your 